相互作用
Buprenorphine + Tranylcypromine
重症度: 併用禁忌
Buprenorphine and Tranylcypromine: contraindicated interaction.
最終更新日
医療従事者向け・参照専用。このページは簡潔な要約であり、医学的助言ではなく、公式の添付文書や臨床判断に代わるものではありません。処方・調剤の前に必ず確認してください。
このページの臨床コンテンツは英語でのみ提供されています。
概要
Combining opioids with a nonselective MAO inhibitor has caused severe reactions such as hypotension, hyperthermia, profound sedation, serotonin toxicity and death. Buprenorphine labeling advises against use during or within 14 days of MAOI treatment.
この相互作用をわかりやすく説明すると
Buprenorphine and Tranylcypromine are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two.
Buprenorphine belongs to Musculoskeletal; Tranylcypromine belongs to Central Nervous System.
なぜ起こるのか
MAO inhibition may potentiate serotonergic and CNS-depressant effects of opioids; the exact mechanism with buprenorphine is not fully defined.
対処法
Do not use together; separate by at least 14 days after stopping tranylcypromine and choose a non-interacting analgesic.
薬剤師に尋ねること
- Is there an alternative to one of these two medicines for me?
- If both are essential, who is monitoring me and how often?
- Which symptoms mean I should stop and seek help straight away?
Pro+会員向け
ページ全体を見る
アカウントを作成してPro+トライアルを始めると、BuprenorphineとTranylcypromineの臨床対応の詳細なアドバイス、追加の注記、エビデンスの詳細、処方全体を対象とした相互作用チェッカーを利用できます。
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
WebでPro+を14日間無料でお試し。カード登録不要。
Buprenorphineのその他の相互作用
Tranylcypromineのその他の相互作用
よくある質問
Can I take Buprenorphine with Tranylcypromine?
MediHelp rates the interaction as contraindicated. Buprenorphine and Tranylcypromine are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two. Combining opioids with a nonselective MAO inhibitor has caused severe reactions such as hypotension, hyperthermia, profound sedation, serotonin toxicity and death. Buprenorphine labeling advises against use during or within 14 days of MAOI treatment.
How serious is the interaction between Buprenorphine and Tranylcypromine?
MediHelp rates it contraindicated, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Do not use together; separate by at least 14 days after stopping tranylcypromine and choose a non-interacting analgesic.
What other medicines interact with Buprenorphine?
MediHelp also lists interactions of Buprenorphine with, for example, Alvimopan, Calcium / magnesium / potassium / sodium oxybates, Olanzapine / samidorphan. The full list is on the Buprenorphine page.
完全なモノグラフ、用量、相互作用チェッカーはMediHelpアプリで
MediHelpアプリで、完全なリファレンスを開き、複数薬剤の相互作用をチェックし、用量ツールを利用できます。
